Are "exercise pills" the answer to the growing problem of physical inactivity?

British Journal of Sports Medicine

Volumn 42, Issue 11, 2008, Pages 562-563

  Warden, Stuart J ^a   Fuchs, Robyn K ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; AMP ACTIVATED PROTEIN KINASE AGONIST; EXERCISE PILL; GW 1516; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; UNCLASSIFIED DRUG;

DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HUMAN; IMMOBILIZATION; INSULIN SENSITIVITY; LIFE EXPECTANCY; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; EXERCISE; EXERCISE TOLERANCE; HEALTH BEHAVIOR; HUMANS; MICE; PHYSICAL CONDITIONING, ANIMAL; RIBONUCLEOTIDES; THIAZOLES;

EID: 56549125328     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2008.053512     Document Type: Editorial

References (11)

1. Centers for Disease Control and Prevention. Glossary of terms. http://www.cdc.gov/nccdphp/dnpa/physical/everyone/glossary/index. htm#Other%20Terms (Accessed 19 September 2008).
2. Booth FW, Laye MJ, Lees SJ, et al. Reduced physical activity and risk of chronic disease: the biology behind the consequences. Eur J Appl Physiol 2008;102:381-90.
3. Narkar VA, Downes M, Yu RT, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008;134:405-15.
4. Barish GD, Narkar VA, Evans RM. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 2006;116:590-7.
5. Osler ME, Zierath JR. Adenosine 5′-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology 2008;149:935-41.
6. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007;8:774-85.
7. Hardie DG, Salt IP, Hawley SA, Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 1999;338:717-22.
8. Booth FW, Lees SJ. Fundamental questions about genes, inactivity and chronic diseases. Physiol Genomics 2007;28:146-57.
9. Richter EA, Kiens B, Wojtaszewski JF. Can exercise mimetics substitute for exercise? Cell Metab 2008;8:96-8.
10. Williams RS, Kraus WE. Exercise and health: can biotechnology confer similar benefits? PLoS Med 2005;2:e68.
11. Rantzau C, Christopher M, Alford FP. Contrasting effects of exercise, AICAR and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism. J Appl Physiol 2008;104:363-70.